1. |
Zhou LF, Zhang MS, Hu AH, et al. Selective blockade of NF-kappaB by novel mutated IkappaBalpha suppresses CD3 / CD28-induced activation of memory CD4 + T cells in asthma. Allergy, 2008, 63 :509-517.
|
2. |
alpha, 25 -dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol, 2008, 180: 5211-5221.
|
3. |
Taher YA, van Esch BC, Hofman GA, et al.
|
4. |
孫正, 許哲, 祁小平, 等. 樹突狀細胞-結直腸癌細胞融合疫苗的制備及生物學特性的研究. 醫學研究生學報, 2006, 19: 19-22.
|
5. |
Isomura I, Tsujimura K, Morita A. Antigen-specific peripheral tolerance induced by topical application of NF-kappaB decoy oligodeoxynucleotide. J Invest Dermatol, 2006, 126: 97-104.
|
6. |
關鍵, 鄭碧霞, 程德云. 核因子-κB 在慢性阻塞性肺疾病大鼠肺內的表達及潑尼松對其的影響. 中國呼吸與危重監護雜志,2008, 7: 52-56.
|
7. |
Preciado D, Lin J, Wuertz B, et al. Cigarette smoke activates NFkappa B and induces Muc5b expression in mouse middle ear cells.Laryngoscope, 2008, 118: 464-471.
|
8. |
Wu K, Bi Y, Sun K, et al. Suppression of allergic inflammation by allergen-DNA-modified dendritic cells depends on the induction of Foxp3 + Regulatory T cells. Scand J Immunol, 2008, 67: 140-151.
|
9. |
Lu L, Lee WC, Takayama T, et al. Genetic engineering of dendritic cells to express immunosuppressive molecules ( viral IL-10, TGFbeta,and CTLA4Ig) . J Leukoc Biol, 1999, 66: 293-296.
|
10. |
Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol, 2007, 120: 238-244.
|
11. |
Cruz MT, Duarte CB, Gon alo M, et al. LPS induction of I kappa Balpha degradation and iNOS expression in a skin dendritic cell line is prevented by the janus kinase 2 inhibitor, Tyrphostin b42. Nitric Oxide, 2001 , 5: 53-61 .
|
12. |
Thoeni G, Stoitzner P, Brandacher G, et al. Tetrahydro-4 -aminobiopterin attenuates dendritic cell-induced T cell priming independently from inducible nitric oxide synthase. J Immunol,2005, 174: 7584-7591.
|